染料染色内镜检测结直肠肿瘤:随机对照试验的荟萃分析
该荟萃分析纳入10项随机对照试验共5334例患者,比较染料染色内镜(DBC)与常规结肠镜(CC)对结直肠肿瘤的检出效果。结果显示DBC组腺瘤检出率(48.1% vs 39.3%;RR 1.20,95%CI 1.11-1.29)及进阶腺瘤、无蒂锯齿状腺瘤、人均腺瘤数均高于CC组。作者认为DBC可提高结肠镜关键质量参数,支持其在日常临床实践中的应用。
要点
- DBC组腺瘤检出率48.1% vs CC组39.3%,RR 1.20(95%CI 1.11-1.29),异质性低(I²=29%)。
- 进阶腺瘤检出率RR 1.21(95%CI 1.03-1.42),无蒂锯齿状腺瘤检出率6.1% vs 3.5%,RR 1.68(95%CI 1.15-2.47)。
- 仅纳入高清白光内镜试验的亚组分析仍显示DBC组腺瘤检出率显著升高(RR 1.14,95%CI 1.06-1.23,P=.0004,I²=.0%)。
核心结论
- 随机对照试验的荟萃分析表明,DBC可提高结肠镜的关键质量参数,支持其在日常临床实践中的应用。
研究设计与样本
- 检索4个数据库截至2022年4月,纳入比较DBC与常规结肠镜的随机对照试验,共10项RCT、5334例患者。
- 结肠镜指征为筛查或监测(3项研究)及混合指征(7项研究)。
- 采用随机效应模型计算二分类结局的相对风险(RR)和连续结局的均数差(MD),用I²检验量化异质性,用Cochrane工具评估偏倚风险。
主要发现
- DBC组腺瘤检出率48.1%(95%CI 41.4%-54.8%)vs CC组39.3%(95%CI 33.5%-46.4%),RR 1.20(95%CI 1.11-1.29),异质性低(I²=29%)。
- 进阶腺瘤检出率RR 1.21(95%CI 1.03-1.42),I²=.0%。
- 无蒂锯齿状腺瘤检出率6.1% vs 3.5%,RR 1.68(95%CI 1.15-2.47),I²=9.8%。
- 人均腺瘤数MD .24(95%CI .17-.31),右半结肠人均腺瘤数MD .28(95%CI .14-.43)。
- 仅纳入高清白光内镜试验的亚组分析:腺瘤检出率51.6%(95%CI 47.1%-56.1%)与59.1%(95%CI 54.7-63.3%),RR 1.14(95%CI 1.06-1.23),P=.0004,I²=.0%,P=.50。
关键数值与推荐
- DBC组腺瘤检出率48.1% vs CC组39.3%,RR 1.20(95%CI 1.11-1.29)。
- DBC组进阶腺瘤检出率RR 1.21(95%CI 1.03-1.42)。
- DBC组无蒂锯齿状腺瘤检出率6.1% vs CC组3.5%,RR 1.68(95%CI 1.15-2.47)。
- DBC组人均腺瘤数MD .24(95%CI .17-.31),右半结肠人均腺瘤数MD .28(95%CI .14-.43)。
临床怎么用
- 作者结论认为DBC提高结肠镜关键质量参数,支持其在日常临床实践中的应用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Dye-based chromoendoscopy (DBC) could be effective in increasing the adenoma detection rate (ADR) in patients undergoing colonoscopy, but the technique is time-consuming and its uptake is limited. We aimed to assess the effect of DBC on ADR based on available randomized controlled trials (RCTs). METHODS: Four databases were searched up to April 2022 for RCTs comparing DBC with conventional colonoscopy (CC) in terms of ADR, advanced ADR, and sessile serrated adenoma detection rate as well as the mean adenomas per patient and non-neoplastic lesions. Relative risk (RR) for dichotomous outcomes and mean difference (MD) for continuous outcomes were calculated using random-effect models. The I2 test was used for quantifying heterogeneity. Risk of bias was evaluated with the Cochrane tool. RESULTS: Overall, 10 RCTs (5334 patients) were included. Indication for colonoscopy was screening or surveillance (3 studies) and mixed (7 studies). Pooled ADR was higher in the DBC group versus the CC group (95% CI, 48.1% [41.4%-54.8%] vs 39.3% [33.5%-46.4%]; RR, 1.20 [1.11-1.29]), with low heterogeneity (I2 = 29%). This effect was consistent for advanced ADR (RR, 1.21 [1.03-1.42]; I2 = .0%), sessile serrated adenomas (6.1% vs 3.5%; RR, 1.68 [1.15-2.47]; I2 = 9.8%), and mean adenomas per patient (MD, .24 [.17-.31]) overall and in the right-sided colon (MD, .28 [.14-.43]). A subgroup analysis considering only trials using high-definition white-light endoscopy reduced the heterogeneity while still showing a significant increase in adenoma detection with DBC: 51.6% (95% confidence interval [CI], 47.1%-56.1%) and 59.1% (95% CI, 54.7-63.3%), RR = 1.14 (95% CI, 1.06-1.23), P = .0004, I2 = .0%, P = .50. CONCLUSIONS: Meta-analysis of RCTs showed that DBC increases key quality parameters in colonoscopy, supporting its use in everyday clinical practice.
引用
- Antonelli G, Correale L, Spadaccini M, et al. Dye-based chromoendoscopy for the detection of colorectal neoplasia: meta-analysis of randomized controlled trials. Gastrointest Endosc. 2022. PMID: 35588768. doi:10.1016/j.gie.2022.05.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。